EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

The development and validation of the questionnaire My Experience with ADHD Pharmacotherapy – Parent Report (ME WAPH-P)

Lilac Mosco iD, Hagai Maoz, Talia Saker, Nadav Weisler, Yuval Bloch

European Child & Adolescent Psychiatry · 2026-12 · 35 (12) · 3905-3916

DOI: 10.1007/s00787-026-03148-7 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift European Child & Adolescent Psychiatry, online erschienen am 07.08.2026. Verfasst von Lilac Mosco und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Tel Aviv University, Ramat Aviv, 0009-0001, 6221-4018, Israel. lilacmosco@mail.tau.ac.il. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Parents, Medication Adherence, Central Nervous System Stimulants. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tel Aviv University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonadherence to pharmacological treatment for attention-deficit/hyperactivity disorder (ADHD) is common among children and adolescents. Despite well-documented clinical and contextual barriers, to the best of our knowledge no dedicated tool exists to quantify parental challenges in supporting adherence. This study aimed to develop and evaluate the My Experience with ADHD Pharmacotherapy – Parent Report (ME WAPH-P) questionnaire. The ME WAPH-P was developed based on existing instruments, clinical experience, expert input, and literature on nonadherence. The initial 30-item questionnaire assessed adherence-related challenges across six subscales. Parents of children aged 4–18 years who had received ADHD medication were recruited via social media and a commercial survey platform. The final sample included 351 parents. Psychometric evaluation included internal consistency, item discrimination, subscale intercorrelations, and exploratory factor analysis (oblique rotation). After removing one item, the 29-item scale demonstrated excellent internal consistency (Cronbach’s α = 0.90). Subscale reliability demonstrated moderate-to-high intercorrelations. Parallel analysis supported a three-factor structure explaining 44.7% of variance, with moderately correlated factors and some cross-loadings. Parents’ primary concerns focused on adverse effects, doubts about effectiveness and safety, summer treatment breaks, and child resistance. Parents of children treated for less than one year reported significantly higher challenge scores, supporting criterion validity. The current preliminary study supports the potential of the ME WAPH-P in capturing a broad, multidimensional construct of parental challenges in ADHD medication adherence. Findings highlighted child resistance as an underexplored barrier. The dimensionality of the questionnaire construct suggests a cumulative “adherence burden”. This novel tool may support clinical identification and monitoring of adherence challenges with implications for targeted clinical intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Attention Deficit Disorder with HyperactivityParentsMedication AdherenceCentral Nervous System StimulantsHumansChildSurveys and QuestionnairesMaleFemalePsychometricsAdolescentChild, PreschoolReproducibility of Results

Stichwörter der Autor:innen

ADHDAdherenceParent reportPharmacotherapyQuestionnaire development

Substanzen

Central Nervous System Stimulants

Autor:innen und Institutionen

  • School of Medicine, Tel Aviv University, Ramat Aviv, 0009-0001, 6221-4018, Israel. lilacmosco@mail.tau.ac.il.
  • School of Medicine, Tel Aviv University, Ramat Aviv, 0009-0001, 6221-4018, Israel.
  • Shalvata- Mental Health Center, Affiliated to Tel-Aviv University Medical School, P.O.B. 94, Hod Hasharon, 45100, 0000-0002, 3155-903X, Israel.
  • Shalvata- Mental Health Center, P.O.B. 94, Hod Hasharon, 45100, Israel.
  • Data Research Center for Mental Health and Rehabilitation, Clalit Health Services, Petach Tikva, Israel.
  • Psychology Department, The Hebrew University, Jerusalem, Israel.

ORCID-Profile: Lilac Mosco

Förderung

  • Tel Aviv University

Zitieren

APA

Mosco, L., Maoz, H., Saker, T., Weisler, N., & Bloch, Y. (2026). The development and validation of the questionnaire My Experience with ADHD Pharmacotherapy – Parent Report (ME WAPH-P). European Child & Adolescent Psychiatry, 35(12), 3905-3916. https://doi.org/10.1007/s00787-026-03148-7

Vancouver

Mosco L, Maoz H, Saker T, Weisler N, Bloch Y. The development and validation of the questionnaire My Experience with ADHD Pharmacotherapy – Parent Report (ME WAPH-P). European Child & Adolescent Psychiatry. 2026;35(12):3905-3916. doi:10.1007/s00787-026-03148-7

BibTeX
@article{Mosco2026,
  author = {Mosco, Lilac and Maoz, Hagai and Saker, Talia and Weisler, Nadav and Bloch, Yuval},
  title = {The development and validation of the questionnaire My Experience with ADHD Pharmacotherapy – Parent Report (ME WAPH-P)},
  journal = {European Child & Adolescent Psychiatry},
  year = {2026},
  volume = {35},
  number = {12},
  pages = {3905--3916},
  doi = {10.1007/s00787-026-03148-7}
}
Kostenlos starten →